PTCT

#2359
PTC Therapeutics, Inc. - Common Stock
73.8 5 USD
+3.94%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
73.85
73.85
Faixa anual
44.17
87.50
Mudança diária
+3.94%
Mudança mensal
+13.98%
Mudança em 6 meses
-11.23%
Mudança anual
+50.99%
Fechamento anterior
71.0 5
Open
73.8 5
Mínimo
73.8 5
High
73.8 5
Volume
158
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 612.58 M
  • Employee 991
  • Founded 1998
  • CEO Matthew B. Klein
  • Website www.ptcbio.com
  • Headquarter Delaware, United States
  • FIGI BBG000QT15P7
  • Industry Biotecnologia
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
9.76
Índice preço/fluxo de caixa
3.88

PTC Therapeutics, Inc. - Common Stock

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control mechanisms in orphan diseases. In September 2009, PTC entered into an agreement with Roche for the development of orally bioavailable small molecules for central nervous system diseases. PTC acquired the Bio-e platform in 2019.

Notícias